NN is trading down 5.18% at $3.81 on October 30, 2026; no reliable report identifies a specific catalyst.

  • Latest company news was strong Q3 results and raised 2026 guidance; shares had risen in preceding sessions after the release, but coverage does not establish that it caused today’s drop.
  • The decline runs counter to the supplied recent trend, including a 4.21% gain on October 29.
  • The provided healthcare sector context does not explain the decline; NN is an industrial manufacturer.